Canopy Growth Corporation (T:WEED*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 1 Hershey Dr
Tel: N/A
IR: See website
Key People
John K. Bell
Independent Chairman of the Board
Rade Nikola Kovacevic
Mark Zekulin
Chief Executive Officer
Mike Lee
Acting Chief Financial Officer
Olivier Dufourmantelle
Senior Vice President - Strategic Expansion and Continuous Improvement
Mark Ware
Chief Medical Officer
Business Overview
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
Financial Overview
For the three months ended 30 June 2019, Canopy Growth Corp revenues increased from C$25.9M to C$90.5M. Net loss increased from C$80.3M to C$1.28B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Share-based compensation expense increase from C$23.1M to C$77.1M (expense), General and administration increase from C$19.6M to C$62.3M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $8,193M as of Jun 30, 2019
Annual revenue (TTM): $290.91M as of Jun 30, 2019
EBITDA (TTM): -$670.73M as of Jun 30, 2019
Net annual income (TTM): -$1,888M as of Jun 30, 2019
Free cash flow (TTM): -$1,351M as of Jun 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 346,658,913 as of Aug 16, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization